Skip to Content

Thiothixene Pregnancy and Breastfeeding Warnings

Thiothixene is also known as: Navane

Thiothixene Pregnancy Warnings

Animal studies revealed some decrease in conception rate and litter size, and an increase in resorption rate. However, animal studies and clinical experience to date have not demonstrated any teratogenic effects. There are no controlled data in human pregnancy. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, and feeding disorder in these neonates. Such complications have varied in severity - symptoms have been self-limited in some while others required intensive care unit support and prolonged hospitalization. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

Safety has not been established during pregnancy; use is recommended only when the expected benefits outweigh the possible risks to mother and fetus. US FDA pregnancy category: Not Assigned

See references

Thiothixene Breastfeeding Warnings

-The manufacturer makes no recommendation regarding use during lactation. -Consider using other antipsychotic agents since there is no published experience with this drug during breastfeeding. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: This drug has caused galactorrhea due to hyperprolactinemia. However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.

See references

References for pregnancy information

  1. "Product Information. Navane (thiothixene)." Roerig Division, New York, NY.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Navane (thiothixene)." Roerig Division, New York, NY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.